Conavi

Toronto, Canada Founded: 2007 • Age: 19 yrs
Catheter-based ultrasound systems for cardiac imaging are developed.
Request Access

About Conavi

Conavi is a company based in Toronto (Canada) founded in 2007.. Conavi has raised $27.7 million across 5 funding rounds from investors including Titan Medical and FedDev Ontario. Conavi offers products and services including Novasight Hybrid System. Conavi operates in a competitive market with competitors including Infraredx, Acarix, Ionetix, Cleveland HeartLab and GlyCardial Diagnostics, among others.

  • Headquarter Toronto, Canada
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Conavi Medical Corp.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $6.55 M (USD)
    322.12
    as on Sep 30, 2025
  • Net Profit
    $-14.74 M (USD)
    52.96
    as on Sep 30, 2025
  • EBITDA
    $-9.91 M (USD)
    46.57
    as on Sep 30, 2025
  • Total Equity Funding
    $27.7 M (USD)

    in 5 rounds

  • Latest Funding Round
    $700.01 K (USD), Post-IPO

    Jan 13, 2026

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Conavi

Conavi is a publicly listed company on the TSXV with ticker symbol CNVI in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: TSXV · Ticker: CNVI . Sector: Health technology · Canada

Products & Services of Conavi

Conavi offers a comprehensive portfolio of products and services, including Novasight Hybrid System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Combines IVUS and OCT for coronary artery imaging and intervention support.

Funding Insights of Conavi

Conavi has successfully raised a total of $27.7M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $700.01 thousand completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Post-IPO — $700,010
  • First Round

    (13 Feb 2019)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2026 Amount Post-IPO - Conavi Valuation

investors

Apr, 2025 Amount Post-IPO - Conavi Valuation

investors

Oct, 2024 Amount Series B - Conavi Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Conavi

Conavi has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Titan Medical and FedDev Ontario. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Robotic surgical systems for single-access procedures are developed.
Founded Year Domain Location
It serves as a government backed investment fund focused on the economic growth of southern ontorio.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Conavi

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Conavi

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Conavi Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Conavi

Conavi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Infraredx, Acarix, Ionetix, Cleveland HeartLab and GlyCardial Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Coronary imaging and plaque detection system
domain founded_year HQ Location
A screening device for acoustic coronary artery diseases is provided.
domain founded_year HQ Location
Superconducting cyclotrons for PET radioisotopes are developed by Ionetix.
domain founded_year HQ Location
Cardiovascular biomarkers are utilized for disease prevention and management.
domain founded_year HQ Location
Apo J-Glyc biomarker is commercialized for cardiac ischemia diagnosis.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Conavi

Frequently Asked Questions about Conavi

When was Conavi founded?

Conavi was founded in 2007 and raised its 1st funding round 12 years after it was founded.

Where is Conavi located?

Conavi is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Is Conavi a funded company?

Conavi is a funded company, having raised a total of $27.7M across 5 funding rounds to date. The company's 1st funding round was a Series B of $7.7M, raised on Feb 13, 2019.

What is the annual revenue of Conavi?

Annual revenue of Conavi is $6.55M as on Sep 30, 2025.

What does Conavi do?

Conavi was founded in 2007 in Toronto, Canada, within the medical devices sector. Operations center on the development of catheter-based ultrasound technology for cardiac applications. The Foresight ICE System has been created, allowing 2D and 3D imaging of cardiac anatomy around the catheter tip. This system supports clinical procedures in cardiology, with focus maintained on imaging precision and integration.

Who are the top competitors of Conavi?

Conavi's top competitors include Acarix, Infraredx and Ionetix.

What products or services does Conavi offer?

Conavi offers Novasight Hybrid System.

Is Conavi publicly traded?

Yes, Conavi is publicly traded on TSXV under the ticker symbol CNVI.

Who are Conavi's investors?

Conavi has 2 investors. Key investors include Titan Medical, and FedDev Ontario.

What is Conavi's ticker symbol?

The ticker symbol of Conavi is CNVI on TSXV.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available